TABLE 2.
Related circRNAs and functions in cervical cancer.
| CircRNA | Function | Sponged miRNA | Modulated pathways in cervical cancer | References |
|---|---|---|---|---|
| Hsa-circ-0000515 | Oncogenic | miR-326 | ELK1, Caspase3, Caspase9, MMP-9, TIMP-1, Beclin1, P62, LC3-I, and LC3-II | Tang et al. (2019) |
| Hsa-circ-0000263 | Oncogenic | miR‐150‐5p | MDM4 and p53 expression | Cai et al. (2019) |
| Hsa-circ-SLC26A4 | Oncogenic | miR-1287-5p | HOXA7 | Ji et al. (2020) |
| Hsa-circ-ITCH | Tumor-suppressive | microRNA-93-5p | Forkhead box K2 (FOXK2) | Li et al. (2020a) |
| Hsa-circ-0141539 | Oncogenic | miR-518d-5p/519-5p | CBX8 protein | Liu et al. (2018b) |
| Hsa-circ-0018289 | Oncogenic | miR-497 | - | Gao et al. (2017) |
| Hsa-circ-0023404 | Oncogenic | miR-136 | TFCP2 and YAP expression | Zhang et al. (2018) |
| Hsa-circ-0011385 | Oncogenic | miR-149-5p | SOX4 expression | Xu et al. (2021) |
| Hsa-circ-0000388 | Oncogenic | miR-337-3p | TCF12 | Meng et al. (2021) |
| Hsa-circ-RBM33 | Oncogenic | miR-758-3p | Pumilio RNA-binding family member 2 (PUM2) | Ding et al. (2021) |
| Hsa-circRNA-0000078 | Oncogenic | miR-205-5p | - | Liu and Li (2023) |
| Hsa-circRNA_101996 | Oncogenic | miR-8075 | TPX2 expression | Song et al. (2019) |
| circRNA-NRIP1 (Hsa-circ-0004771) | Oncogenic | miR-629-3p | PTP4A1/ERK1/2 pathway | Li et al. (2020b) |
| Hsa-circRNA-0000118 | Oncogenic | miR-211-5p/miR-377-3p | AKT2 expression | Wu et al. (2023) |